Familial cancer syndrome is a genetic condition that causes an increased risk for specific types of cancers. Familial cancer syndromes account for only 5-10% of all cancers.
Most cancer is not inherited. Cancer is common; in 2000, over 1.2 million new cancer cases were diagnosed. Many people have relatives who have had cancer, but most of the time this is due to chance or environmental factors. In a familial cancer syndrome, an inherited genetic mutation causes a person to be at increased risk for cancer and other physical symptoms. There are many different familial cancer syndromes, and each one has a specific set of characteristic cancers and physical symptoms associated with it. For example, BRCA1 and BRCA2 gene mutations are associated with an increased risk for breast and ovarian cancer. Examples of other familial cancer syndromes include Von Hippel-Lindau syndrome, Peutz-Jeghers syndrome, and Li-Fraumeni syndrome.
Below is a list of "clues" in a family tree that make a familial cancer syndrome more suspicious:
The most important step in determining if a family has a familial cancer syndrome is gathering an accurate family history. The family history should include children, brothers and sisters, parents, aunts, uncles, grandparents, nieces, nephews and cousins on both sides of the family. For a person who has had cancer, the type of cancer and age at diagnosis should be listed for each cancer. It may be necessary to obtain medical records to confirm what type of cancer a person had since family members may not always be aware of specific information. Birth defects, unusual skin findings, benign tumors, and special
| Suppressor genes that, when deleted, predispose families to cancers | |
| Gene | Consequence of gene loss |
| Rb | Retinoblastoma and osteosarcoma |
| TP53 | Li-Fraumeni syndrome |
| Wt1 | Wilms' tumor |
| VHL | von Hippel-Lindau syndrome; renal cell carcinoma |
| NF1 | von Recklinghausen's disease; neurofibromatosis type 1; schwannoma and glioma |
| NF2 | Neurofibromatosis type 2; acoustic neuroma and meningiomas |
| APC | Familial adenomatous polyposis; colorectal tumors |
| MMR | Hereditary nonpolyposis-colorectal cancer |
screening tests (such as colonoscopy to look for colon polyps) should also be noted. When this type of family information is unavailable, it may be possible to look for clues in one or a small number of family members. Many hospitals have a "familial cancer clinic, " which is a team of health professionals with expertise in familial cancer syndromes. Geneticists, genetic counselors, oncologists and social workers assist individuals and families by providing risk assessment, support, screening and prevention recommendations, and genetic testing options (if available).
Some familial cancer syndromes show autosomal dominant inheritance, which means that an affected person has a 50% chance of passing on the genetic mutation to each of his/her children. Other familial cancer syndromes show autosomal recessive inheritance, which means that both parents are usually not affected, but are carriers of a mutation for the condition. In autosomal recessive inheritance, each child born to parents who are carriers has a 25% chance of having the condition. When a person is diagnosed with a familial cancer syndrome, relatives should be examined for signs of the syndrome. Sometimes a person identified as having a familial cancer syndrome is the first person in the family to be affected. That person is able to pass the condition on to his or her children, but the parents and siblings are not affected. Depending on the syndrome, genetics professionals can determine who in the family is at risk.
Different familial cancer syndromes have different risks for cancer and associated symptoms. In general, a person who inherits the syndrome has a higher risk of developing the cancer associated with the syndrome than the general population, but this is not a guarantee that cancer will ever develop. On the other hand, someone who does not inherit the syndrome is not at increased risk for cancer above that of the general population, but this is no guarantee that cancer will not develop, and screening guidelines for the general population should be followed.
Although genetic testing is available for many familial cancer syndromes, there are genes that have yet to be discovered. Each syndrome has special issues surrounding genetic testing; for example, what age should the test be done? How would the results change medical management? Does insurance cover the test? How will the information affect the family? Health professionals familiar with familial cancer syndromes keep up to date with advances in cancer genetics, and work with families to discuss the risks, benefits and limitations of genetic testing.
Offit, K. Clinical Cancer Genetics: Risk Counseling and Management. New York: Wiley-Liss, 1998.
Cummings, S. "The Genetic Testing Process: How Much Counseling Is Needed?" Journal of Clinical Oncology 18 (1 Nov Supplement 2000): 60-4.
Elsas, L. J., and A. Trepanier. "Cancer genetics in primary care:When is genetic screening an option and when is it the standard of care?" Postgraduate Medicine 107 (April 2000): 191-208.
Lindor, N. M., and M. H. Greene. "The Concise Handbook of Family Cancer Syndromes." Journal of the National Cancer Institute 90 (15 July 1998): 1039-71.
Lynch, H., et al. "Clinical Impact of Molecular Genetic Diagnosis, Genetic Counseling, and Management of Hereditary Cancer: Part I: Studies of Cancer in Families." Cancer 86 (1999): 2449-56.
"Autosomal Dominant Genes." WebMD June 2001. 27 June 2001 <http://my.webmd.com/content/asset/adam_imagepage_9084>.
"Statistics." American Cancer Society June 2001. 27 June 2001<http://www3.cancer.org/cancerinfo/>.
Laura L. Stein, M.S., C.G.C.
—A unit of heredity that codes for the formation of a protein. Genes determine how we grow and develop.
—Qualities that are transmitted from parent to offspring in the genes.
—A change in a genetic code which may result in altered function of a gene.
—The clustering of signs and symptoms that characterize a disease.